Circulating tumor cells: utopia or reality?

被引:18
作者
Conteduca, Vincenza [1 ]
Zamarchi, Rita [2 ]
Rossi, Elisabetta [3 ]
Condelli, Valentina [4 ]
Troiani, Laura [4 ]
Aieta, Michele [4 ]
机构
[1] IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Dept Med Oncol, I-47014 Meldola, FC, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Univ Padua, Oncol Sect, Dept Surg Oncol & Gastroenterol, I-35100 Padua, Italy
[4] Ctr Riferimento Oncol Basilicata IRCCS, Rionero In Vulture, Italy
关键词
circulating tumor cell; detection method; epithelial-mesenchymal transition; metastasis; molecular characterization; prognosis; METASTATIC BREAST-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; PERIPHERAL-BLOOD; MOLECULAR CHARACTERIZATION; PROGNOSTIC-SIGNIFICANCE; BONE-MARROW; CLINICAL-RELEVANCE; LUNG-CANCER; SURVIVAL; EXPRESSION;
D O I
10.2217/fon.13.101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circulating tumor cells (CTCs) could be considered a sign of tumor aggressiveness, but highly sensitive and specific methods of CTC detection are necessary owing to the rarity and heterogeneity of CTCs in peripheral blood. This review summarizes recent studies on tumor biology, with particular attention to the metastatic cascade, and the molecular characterization and clinical significance of CTCs. Recent technological approaches to enrich and detect these cells and challenges of CTCs for individualized cancer treatment are also discussed. This review also provides an insight into the positive and negative features of the future potential applications of CTC detection, which sometimes remains still a utopia', but its actual utility remains among the fastest growing research fields in oncology.
引用
收藏
页码:1337 / 1352
页数:16
相关论文
共 109 条
  • [1] Models, mechanisms and clinical evidence for cancer dormancy
    Aguirre-Ghiso, Julio A.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (11) : 834 - 846
  • [2] Alix-Panabieres Catherine, 2012, Recent Results Cancer Res, V195, P69, DOI 10.1007/978-3-642-28160-0_6
  • [3] Circulating Tumor Cells and Circulating Tumor DNA
    Alix-Panabieres, Catherine
    Schwarzenbach, Heidi
    Pantel, Klaus
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 63, 2012, 63 : 199 - 215
  • [4] Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system
    Andreopoulou, E.
    Yang, L. -Y.
    Rangel, K. M.
    Reuben, J. M.
    Hsu, L.
    Krishnamurthy, S.
    Valero, V.
    Fritsche, H. A.
    Cristofanilli, M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) : 1590 - 1597
  • [5] [Anonymous], 2010, AJCC Cancer Staging Manual, V7th, P347
  • [6] Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance
    Apostolaki, S.
    Perraki, M.
    Pallis, A.
    Bozionelou, V.
    Agelaki, S.
    Kanellou, P.
    Kotsakis, A.
    Politaki, E.
    Kalbakis, K.
    Kalykaki, A.
    Vamvakas, L.
    Georgoulias, V.
    Mavroudis, D.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (05) : 851 - 858
  • [7] Ashworth T.R., 1869, Australas Med J, V14, P146
  • [8] Real- time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer
    Benoy, IH
    Elst, H
    Philips, M
    Wuyts, H
    Van Dam, P
    Scharpé, S
    Van Marck, E
    Vermeulen, PB
    Dirix, LY
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (05) : 672 - 680
  • [9] Bhagat Ali Asgar S, 2012, Recent Results Cancer Res, V195, P59, DOI 10.1007/978-3-642-28160-0_5
  • [10] Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
    Bidard, F. -C.
    Vincent-Salomon, A.
    Sigal-Zafrani, B.
    Dieras, V.
    Mathiot, C.
    Mignot, L.
    Thiery, J. -P.
    Sastre-Garau, X.
    Pierga, J. -Y.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (03) : 496 - 500